TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol

INTRODUCTION: Pharmaceutical treatment options for patients with type 2 diabetes mellitus (T2DM) have increased to include multiple classes of oral glucose-lowering agents but without accompanying guidance on which of these may most benefit individual patients. Clinicians lack information for treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Angwin, Catherine, Jenkinson, Caroline, Jones, Angus, Jennison, Christopher, Henley, William, Farmer, Andrew, Sattar, Naveed, Holman, Rury R, Pearson, Ewan, Shields, Beverley, Hattersley, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754630/
https://www.ncbi.nlm.nih.gov/pubmed/33371044
http://dx.doi.org/10.1136/bmjopen-2020-042784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754630/
https://www.ncbi.nlm.nih.gov/pubmed/33371044
http://dx.doi.org/10.1136/bmjopen-2020-042784

Ejemplares similares